Our Leadership Team

Patrick van Berkel, PhD

Chief Scientific Officer
Patrick van Berkel

Dr. van Berkel has more than 20 years of experience in the biotech industry, specializing in the development of antibody-based therapeutics.

Prior to joining ADC Therapeutics, Dr. van Berkel spent more than 9 years with Genmab in various roles, including Vice President of Antibody Technology and Vice President of CMC R&D.

Dr. van Berkel has a chemistry degree from the University of Nijmegen, The Netherlands (1991) and did his thesis at the University of Leiden, The Netherlands (1998).

Back to Our Leadership Team